COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20090117001556N138


Column Value
Trial registration number IRCT20090117001556N138
Full text link
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Dr. Mohammad Ali Sahraian

Contact
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

msahrai@tums.ac.ir

Registration date
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-08-03

Recruitment status
Last imported at : Sept. 23, 2023, noon
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Long covid

Inclusion criteria
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

History of hospitalization due to COVID-19 At least 20 days from the onset of symptoms, and 7 days from the last day of symptoms passed Diagnosis of cognitive impairment (score 23 or less in MMSE test, or score 22 or less in MoCA test) Age between 18-65

Exclusion criteria
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Being psychotic Presence of other psychiatric disorders Using other psychiatric drugs or any drug which can affect cognitive performance History of ECT during past 2 months Presence of thyroid disease Presence of kidney disease Presence of liver disease History of cognitive impairment or dementia Pregnant or lactating women

Number of arms
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Tehran University of Medical Sciences

Inclusion age min
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

65

Countries
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Patients recovered from covid

Severity scale
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

N/A

Total sample size
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

50

primary outcome
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Severity of cognitive impairment

Notes
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 2/Phase 3

Arms
Last imported at : Aug. 3, 2021, 3:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 503, "treatment_name": "Famotidine", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]